⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PGEN News
Precigen, Inc. Common Stock
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
prnewswire.com
PGEN
PGEN
Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright
prnewswire.com
PGEN
PGEN